Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
P274. Response to intravenous steroid therapy in the first few days of hospitalization determines the subsequent risk of colectomy in newly diagnosed ulcerative colitis patients
P274

Diagnostic accuracy of fecal calprotectin and M2-pyruvate kinase in the prediction of endoscopic activity Crohn's disease

Authors:

V.M. Juan María*, P.-M. Héctor, B.-R. Beatriz, O.-M. Rosario, C.-C. Manuel, R.-L. Manuel

Hospital General Juan Ramón Jiménez, UGC Aparato Digestivo, Huelva, Spain

P275.

Bile acid malabsorption involvement in Crohn's disease symptoms. Its relationship with ROME III criteria

Authors:

A. Ruiz-Cerulla1, F. Rodriguez-Moranta1, L. Rodriguez-Alonso1, C. Àrajol1, T. Lobatón Ortega1, S. Maisterra1, E. Sanchez Pastor1, O. Puig-Calvo2, J. Martín-Comín2, J. Guardiola1, 1Bellvitge University Hospital, Gastroenterology, Barcelona, Spain, 2Bellvitge University Hospital, Nuclear Medicine, Barcelona, Spain

P275. Clinical response is a meaningful endpoint in ulcerative colitis clinical studies
Authors:

W. Sandborn1, B. Feagan2, C. Marano3, R. Strauss3, C. Han4, J. Johanns3, H. Zhang3, C. Guzzo3, J.-F. Colombel5, W. Reinisch6, P. Gibson7, J. Collins8, G. Jarnerot9, P. Rutgeerts10, 1University of California San Diego, United States, 2Robarts Research Institute, Canada, 3Janssen Research & Development, LLC, United States, 4Janssen Global Services LLC, United States, 5Hôpital Claude Huriez, France, 6Universitätsklinik für Innere Medizin IV, Austria, 7Alfred Hospital, Melbourne, Australia, 8Oregon Health Sciences University, United States, 9Orebro University Hospital, Sweden, 10University Hospital, Gasthuisberg, Belgium

P275. Evaluation of the discontinuation of infliximab during pregnancy in inflammatory bowel disease patients
P275. Non-organ specific autoantibodies (NOSA) on TNF-α antagonists: A study in 40 patients with inflammatory bowel disease (IBD)
P275

Relevance of ultrasonographic parameters in predicting inflammatory bowel disease in a pediatric population.

Authors:

A. Dell'Era*1, D. Dilillo2, E. Galli2, F. Meneghin3, F. Furfaro1, C. Bezzio1, F. Penagini2, C. Mantegazza2, F. Scrignoli2, G.V. Zuccotti2, G. Maconi1

1Ospedale L. Sacco. Gastroenterology Unit, Università degli Studi di Milano, Department of Biomedical and Clinical Sciences, Milan, Italy, 2Ospedale dei Bambini V. Buzzi, Università degli Studi di Milano, Department of Paediatrics, Milan, Italy, 3Ospedale L. Sacco. Università degli Studi di Milano, Department of Paediatrics, Milan, Italy

P276.

Association between serum 25-hydroxy vitamin D concentration and inflammatory bowel disease characteristics in North-Eastern Romania

Authors:

G. Dumitrescu, C. Mihai, M. Dranga, C. Cijevschi Prelipcean, University of Medicine and Pharmacy “Gr. T. Popa”, Iasi, Institute of Gastroenterology and Hepatology, Iasi, Romania

P276. An exploration of the health and social needs of people living with inflammatory bowel disease: A metasynthesis
P276. Clinical outcomes of children with prenatal exposure to anti-TNF therapy for maternal inflammatory bowel disease
Authors:

N.A. Yassin1, T. Tyrrell2, H. Middleton2, M. O'Connor2, N. Arebi2, A.L. Hart3, 1St Mark's Hospital and Academic Institute, Harrow, The Department of Colorectal Surgery, London, United Kingdom, 2IBD Unit, St Mark's Hospital, Harrow, London, United Kingdom, 3IBD Unit, St Mark's Hospital and Academic Institute, Harrow, London, United Kingdom

P276. Efficacy and effectiveness of biological therapy in inflammatory bowel disease (IBD): Comparative study between clinical practice and pivotal studies
P276

Evaluation of histological parameters in patients with clinical remission of ulcerative colitis

Authors:

E. Kondrashina*1, O. Schukina1, A. Kharitidis2, A. Botina3, E. Markova2

1North-Western state medical university named after I.I. Mechnikov, Department of Gastroenterology and Dietology, St-Petersburg, Russian Federation, 2City clinical hospital №31, St-Petersburg, Russian Federation, 3The First Pavlov State Medical University of St. Peterburg, Department of Patologic Anatomy, St-Petersburg, Russian Federation

P277.

Assessment of the performance of the colonic PillCam PCC2 in Crohn's patients

Authors:

A. Van Gossum1, D. Franchimont1, L. Amininejad1, G. D'Haens2, 1Hôpital Erasme, Gastroenterology, Brussels, Belgium, 2AMC, Gastroenterology, Amsterdam, Netherlands

P277. Clinical features and natural history of patients diagnosed with asymptomatic ulcerative colitis
Authors:

S.K. Park1, B.D. Ye1, S.K. Yang1, J.W. Kim1, S.H. Park1, D.H. Yang1, K.W. Jung1, K.J. Kim1, J.S. Byeon1, S.J. Myung1, J.H. Kim1, 1Asan Medical Center, Gastroenterology, Seoul, South Korea

P277. How frequent are misconceptions in the management of outpatients with inflammatory bowel disease?
P277. Optimal C-reactive protein cutoff point for predicting hospitalization in patients with moderately active Crohn's disease
P277

S. Jiménez*1, V.M. Navas2, J. Martín-De-Carpi3, A. Rodríguez4, S. López-Cuesta5, Ó. Segarra6, J.I. García-Burriel7, E. Donat8, J. Barrio9, V. Crujeiras10, H. Armas11, L. Ortigosa12, R. García-Romero13, H. Lorenzo14, Z. García-Casales15, P. Barros16, P. Oliver17, C. Ochoa18, J.M. Bartolomé19, E. La Orden20, J.J. Díaz-Martín1

Authors:

1Hospital Universitario Central de Asturias, Paediatric Gastroenterology and Nutrition Unit, Oviedo, Spain, 2Hospital Regional Universitario Carlos Haya, Málaga, Paediatric Gastroenterology and Nutrition Unit, Málaga, Spain, 3Hospital Sant Joan de Déu, Paediatric IBD Unit, Barcelona, Spain, 4Hospital Universitario Virgen Del Rocio, Paediatric Gastroenterology and Nutrition Unit, Sevilla, Spain, 5Hospital Universitario Donostia, Paediatric Gastroenterology and Nutrition Unit, San Sebastián, Spain, 6Hospital Universitari Vall d'Hebron, Paediatric Gastroenterology and Nutrition Unit, Barcelona, Spain, 7Complexo Hospitalario Universitario de Vigo, Paediatric Gastroenterology and Nutrition Unit, Vigo, Spain, 8Hospital Universitari I Politècnic La Fe, Paediatric Gastroenterology and Nutrition Unit, Valencia, Spain, 9Hospital Universitario de Fuenlabrada, Paediatric Gastroenterology and Nutrition Unit, Fuenlabrada, Spain, 10Hospital Clínico Universitario de Santiago, Paediatric Gastroenterology and Nutrition Unit, Santiago de Compostela, Spain, 11Hospital Universitario de Canarias, Paediatric Gastroenterology and Nutrition Unit, La Laguna, SantaCruz de Tenerife, Spain, 12Hospital Nuestra Sra de Candelaria, Paediatric Gastroenterology and Nutrition Unit, Santa Cruz de Tenerife, Spain, 13Hospital Universitario Miguel Servet, Paediatric Gastroenterology and Nutrition Unit, Zaragoza, Spain, 14Hospital Universitario de Basurto, Paediatric Gastroenterology and Nutrition Unit, Bilbao, Spain, 15Hospital Univesrsitario de Álava-Txagorritxu, Paediatric Gastroenterology and Nutrition Unit, Vitoria, Spain, 16Hospital San Pedro de Alcántara, Paediatric Gastroenterology and Nutrition Unit, Cáceres, Spain, 17Hospital de Mendaro, Paediatric Gastroenterology and Nutrition Unit, Mendaro, Spain, 18Hospital Virgen de la Concha, Paediatric Gastroenterology and Nutrition Unit, Zamora, Spain, 19Complejo Hospitalario Río Carrión, Paediatric Gastroenterology and Nutrition Unit, Palencia, Spain, 20Hospital Universitario Infanta Elena, Paediatric Gastroenterology and Nutrition Unit, Valdemoro, Spain

P278.

Aspects that determine patient satisfaction in the management of mild to moderate ulcerative colitis: a Delphi study of patients and physicians

Authors:

F. Casellas1, D. Ginard2, S. Riestra3, A.J. Blasco4, P. Lazaro4, 1Hospital Universitari Vall d'Hebron, Unitat Atenció Crohn-Colitis, Barcelona, Spain, 2Hospital Universitario Son Espases, Gastroenterology Department, Palma de Mallorca, Spain, 3Hospital Universitario Central de Asturias, Gastroenterology Department, Oviedo, Spain, 4Advanced Techniques in Health Services Research (TAISS), Research, Madrid, Spain

P278. Clinical comparison of eight different calprotectin immunoassays for the diagnosis and follow-up of inflammatory bowel disease
Authors:

D. Labaere1, A. Smismans1, G. Van Olmen2, P. Christiaens2, G. D'Haens2, V. Moons2, P.-J. Cuyle2, J. Frans1, P. Bossuyt2, 1Imelda general hospital Bonheiden, Laboratory Medicine, Bonheiden, Belgium, 2Imelda general hospital Bonheiden, Gastroenterology, Bonheiden, Belgium

P278. Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: A multicenter experience